semaglutide off‑target side effects
Stop Losing Progress to Semaglutide Stagnation
Three out of four people who stop GLP-1 therapy do so because of progress plateaus or persistent side effects, while only 1% of bariatric surgery patients later resume medication. To keep weight loss moving, clinicians should manage semaglutide’s off-target effects, plan structured discontinuation, and consider timely surgical referral. Medical